Add time:08/20/2019         Source:sciencedirect.com

A series of 3-(hetero)aryl substituted 3-[(prop-2-ynyloxy)(thiophen-2-yl)methyl]pyridine derivatives were designed as potential anticancer agents. These compounds were conveniently prepared by using Pd/C–Cu mediated Sonogashira type coupling as a key step. Many of these compounds were found to be promising when tested for their in vitro anti-proliferative properties against six cancer cell lines. All these compounds were found to be selective towards the growth inhibition of cancer cells with IC50 values in the range of 0.9–1.7 μM (against MDA-MB 231 and MCF7 cells), comparable to the known anticancer drug doxorubicin.

We also recommend Trading Suppliers and Manufacturers of PYRIDINE-2-YL DIPHENYLMETHANOL (cas 19490-90-5). Pls Click Website Link as below: cas 19490-90-5 suppliers